Investors

Insider Transactions

Date Name Title Type Sorted Descending Shares Traded Price Range
Jun 30, 2011 vagelos p roy Officer Disposition (Non Open Market) 3,798 n/a
Jun 18, 2010 vagelos p roy Director Disposition (Non Open Market) 31,761 n/a
Jul 2, 2010 vagelos p roy Director Disposition (Non Open Market) 9,021 n/a
Jul 7, 2010 vagelos p roy Director Disposition (Non Open Market) 125,000 n/a
Jan 12, 2012 vagelos p roy Officer Disposition (Non Open Market) 3,786 n/a
Mar 30, 2012 vagelos p roy Officer Disposition (Non Open Market) 1,852 n/a
Jul 12, 2012 vagelos p roy Officer Disposition (Non Open Market) 1,860 n/a
Jul 24, 2012 vagelos p roy Officer Disposition (Non Open Market) 59,841 n/a
Apr 4, 2011 vagelos p roy Officer Disposition (Non Open Market) 4,954 n/a
Sep 4, 2012 vagelos p roy Officer Disposition (Non Open Market) 19,947 n/a
Oct 9, 2012 vagelos p roy Officer Disposition (Non Open Market) 1,392 n/a
Jan 12, 2011 vagelos p roy Officer Disposition (Non Open Market) 1,203 n/a
Mar 29, 2008 vagelos p roy Director Disposition (Non Open Market) 10,669 n/a
Jul 5, 2013 vagelos p roy Officer Disposition (Non Open Market) 921 n/a
Oct 2, 2013 vagelos p roy Officer Disposition (Non Open Market) 73,596 n/a
Oct 9, 2013 vagelos p roy Officer Disposition (Non Open Market) 679 n/a
Jan 8, 2013 vagelos p roy Officer Disposition (Non Open Market) 1,254 n/a
Apr 4, 2013 vagelos p roy Officer Disposition (Non Open Market) 1,215 n/a
Apr 27, 2012 van plew daniel p Officer Disposition (Non Open Market) 15,990 138.36
Oct 25, 2012 van plew daniel p Officer Disposition (Non Open Market) 16,043 159.55
Showing 401-420 of 773 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)